Level Chart

Basic Info

Johnson & Johnson (JNJ) - Pharmaceutical Revenue is at a current level of 52.56B, up from 45.57B one year ago. This is a change of 15.34% from one year ago.

Pharmaceutical Revenue refers to the total revenue generated by Johnson & Johnson from its pharmaceutical segment.

Region United States
Source FinChat.io

Data provided via FinChat.io

Stats

Last Value 52.56B
Latest Period 2023
Last Updated Jan 12 2024, 16:52 EST
Average Growth Rate 7.70%
Value from 1 Year Ago 45.57B
Change from 1 Year Ago 15.34%
Frequency Yearly
Unit USD
Adjustment N/A

Historical Data

View and export this data back to 2012. Upgrade now.
Date Value
January 01, 2023 52.56B
January 02, 2022 51.68B
January 03, 2021 45.57B
December 29, 2019 42.20B
December 30, 2018 40.73B
December 31, 2017 36.26B
Date Value
January 01, 2017 33.46B
January 03, 2016 31.43B
December 28, 2014 32.31B
December 29, 2013 28.12B
December 30, 2012 25.35B

Basic Info

Johnson & Johnson (JNJ) - Pharmaceutical Revenue is at a current level of 52.56B, up from 45.57B one year ago. This is a change of 15.34% from one year ago.

Pharmaceutical Revenue refers to the total revenue generated by Johnson & Johnson from its pharmaceutical segment.

Region United States
Source FinChat.io

Data provided via FinChat.io

Stats

Last Value 52.56B
Latest Period 2023
Last Updated Jan 12 2024, 16:52 EST
Average Growth Rate 7.70%
Value from 1 Year Ago 45.57B
Change from 1 Year Ago 15.34%
Frequency Yearly
Unit USD
Adjustment N/A

Related Securities

Symbol Name Change %
JNJ Johnson & Johnson -0.02%